Mahadevan A, Siegel C, Martin B R, Abood M E, Beletskaya I, Razdan R K
Organix, Inc., 240 Salem Street, Woburn, Massachusetts 01801, USA.
J Med Chem. 2000 Oct 5;43(20):3778-85. doi: 10.1021/jm0001572.
The observation that the phenolic hydroxyl of THCs was important for binding to the CB1 receptor but not as critical for binding to the CB2 receptor prompted us to extend this finding to the cannabinol (CBN) series. To study the SAR of CBN analogues, CBN derivatives with substitution at the C-1, C-3, and C-9 positions were chosen since these positions have played a key role in the SAR of THCs. CBN-3-(1',1'-dimethylheptyl) analogues were prepared by sulfur dehydrogenation of Delta(8)-THC-3-(1',1'-dimethylheptyl) analogues. 9-Substituted CBN analogues were prepared by the standard sulfur dehydrogenation of 9-substituted Delta(8)-THC analogues (Scheme 1), which in turn were prepared following our previous procedure using selenium dioxide oxidation of the corresponding Delta(8)-THCs followed by sodium chlorite oxidation to give the 9-carboxy-Delta(8)-THC derivatives. 11-Hydroxy-CBN analogues were prepared from the corresponding 9-carbomethoxy-CBN analogues by reduction with LiAlH(4). Deoxy-CBN analogue 14 was prepared from the corresponding Delta(8)-THC analogue 11 by conversion of the phenolic hydroxyl to the phosphate derivative 12, followed by lithium ammonia reduction to provide the deoxy-Delta(8)-THC analogue 13, which in turn was dehydrogenated with sulfur to provide the deoxy-CBN analogue 14 (Scheme 2). The various analogues were assayed for binding both to the brain and the peripheral cannabinoid receptors (CB1 and CB2). We have found that the binding profile differs widely between the CBN and the THC series. Specifically, in the CBN series the removal of the phenolic hydroxyl decreases binding affinity to both the CB1 and CB2 receptors, whereas in the THC series, CB1 affinity is selectively reduced. Thus, in the CBN series, the selectivity of binding observed with the removal of the hydroxy group is decreased severalfold as compared to what occurs in the THC series. Generally, high affinity for the CB2 receptor was found in analogues when the phenolic hydroxyl was present. The 3-(1', 1'-dimethylheptyl) derivatives were found to have much higher affinities than the CBN analogues, which is in complete agreement with previously reported work by Rhee et al.
四氢大麻酚(THC)的酚羟基对于与CB1受体结合很重要,但对与CB2受体结合并非至关重要,这一观察结果促使我们将这一发现扩展到大麻酚(CBN)系列。为了研究CBN类似物的构效关系(SAR),选择了在C-1、C-3和C-9位有取代基的CBN衍生物,因为这些位置在THC的构效关系中起关键作用。CBN-3-(1',1'-二甲基庚基)类似物通过Δ(8)-THC-3-(1',1'-二甲基庚基)类似物的硫脱氢反应制备。9-取代的CBN类似物通过9-取代的Δ(8)-THC类似物的标准硫脱氢反应制备(方案1),而这些9-取代的Δ(8)-THC类似物又按照我们之前的方法制备,即先用二氧化硒氧化相应的Δ(8)-THC,然后用亚氯酸钠氧化得到9-羧基-Δ(8)-THC衍生物。11-羟基-CBN类似物由相应的9-甲氧基羰基-CBN类似物用LiAlH(4)还原制备。脱氧-CBN类似物14由相应的Δ(8)-THC类似物11制备,先将酚羟基转化为磷酸酯衍生物12,然后用锂氨还原得到脱氧-Δ(8)-THC类似物13,再用硫将其脱氢得到脱氧-CBN类似物14(方案2)。对各种类似物进行了与脑和外周大麻素受体(CB1和CB2)结合的测定。我们发现CBN系列和THC系列的结合情况差异很大。具体来说,在CBN系列中,酚羟基的去除会降低与CB1和CB2受体的结合亲和力,而在THC系列中,CB1亲和力会选择性降低。因此,在CBN系列中,与THC系列相比,去除羟基后观察到的结合选择性降低了几倍。一般来说,当存在酚羟基时,类似物对CB2受体具有高亲和力。发现3-(1',1'-二甲基庚基)衍生物的亲和力比CBN类似物高得多,这与Rhee等人之前报道的工作完全一致。